BioBridgeXAll companies

Humacyte, Inc.

Biotechnology company · Durham, North Carolina, United States · Nasdaq: HUMA

Humacyte, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its shares trade on Nasdaq under the ticker HUMA. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $7.5 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $150 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Humacyte at a glance

Typebiotechnology company
HeadquartersDurham, North Carolina, United States
Stock listingNasdaq: HUMA
SEC industryBiological Products, (No Diagnostic Substances)
FDA-registered sites1
Employees (per SBIR records)30

What does Humacyte do?

Operations at its FDA-registered drug sites

AnalysisLabelingManufacturingPacking

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $7.5 million in total (2010 to 2014).

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $150 million sold (2018).

Where is Humacyte located?

Headquarters: Durham, North Carolina, United States

  • Durham, North CarolinaHumacyte Global, Inc · FDA drug site

Frequently asked questions about Humacyte

Where is Humacyte headquartered?

Humacyte, Inc. is headquartered in Durham, North Carolina, United States.

What does Humacyte do?

Humacyte, Inc. is a biotechnology company. Its FDA-registered drug sites are registered for analysis, labeling, manufacturing and packing. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Humacyte a public company?

Yes. Humacyte, Inc. trades on Nasdaq under the ticker HUMA.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.